PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.\', \'Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.\', \'Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, New York.\', \'Translational Oncology and Urology Research (TOUR), King\'s College London, Guy\'s Hospital, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0255966
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34618806
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all